SEC Form 4 · accession 0001179110-18-000601
Traws Pharma, Inc. · TRAW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Patrick Guerin
Officer — Chief Financial Officer
Period of report
Jan 3, 2018
Accepted (ET)
Jan 5, 2018 · 4:49 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001130598
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to purchase)F1 | $1.50 | Jan 3, 2018 | A | 31,024 | A | — | Jan 3, 2028 | Common Stock | 31,024 | 31,024 | D |
Explanation of responses
- F1These options vest over three years in 36 equal monthly installments.